HealthAugust 10, 2026
reboxetine
ree-BOX-uh-teen
Definition
A selective norepinephrine reuptake inhibitor and cortical dopamine modulator used as a pharmacological treatment for symptoms of narcolepsy, specifically cataplexy.
Etymology
The name is a portmanteau derived from its chemical structure and pharmacological class as a reuptake inhibitor. It follows standard pharmaceutical naming conventions that often blend parts of chemical descriptors to distinguish the drug in medical literature.
In the news
In this article, reboxetine is identified as the active ingredient in the experimental drug AXS-12, which was shown in clinical trials to significantly reduce cataplexy attacks in patients with narcolepsy.
New in Narcolepsy: Pharmacology Updates
Read the full article ↗Psychiatric Times